Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 7/7/2020
SIETES contiene 93061 citas

 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Hean-Philippe P, Palumbo P. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. N Engl J Med 2012;366:2380-9. [Ref.ID 93319]
2.Tiene citas relacionadas
Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Shimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Violari A. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010;363:1510-20. [Ref.ID 89498]
3.Tiene citas relacionadas Cita con resumen
Hughes MD, Williams PL. Challenges in using observational studies to evaluate adverse effects of treatment. N Engl J Med 2007;356:1705-7. [Ref.ID 79878]
4.Tiene citas relacionadas Cita con resumen
Hughes MD, Soh CH, Brady MT, Dankner WM, Oleske JM. Long-term effects of protease-inhibitor-based combination therapy. Authors' reply. Lancet 2004;363:900-1. [Ref.ID 69449]
5. Cita con resumen
Soh CH, Oleske JM, Brady MT, Spector SA, Borkowsky W, Burchett SK, Foca MD, Handelsman E, Jiménez E, Dankner WM, Hughes MD, for the Pediatric AIDS Clinical Trials Group. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003;362:2045-51. [Ref.ID 68527]
Demeter LM, Hughes MD, Coombs RW, Jackson B, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med 2001;135:954-64. [Ref.ID 59905]
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA, for the AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33. [Ref.ID 34638]
Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Stat Med 1997;16:1965-82. [Ref.ID 34202]
Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S, Rasheed S, Elveik T, Reichman R, Japour A, Merigan TC, Hirsch MS. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996;335:1091-8. [Ref.ID 29273]
Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair J P, Niu M, Hirsch MS, Merigan TC. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90. [Ref.ID 29272]
11. Cita con resumen
D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou S, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS, National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Neviparine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. Ann Intern Med 1996;124:1019-30. [Ref.ID 28163]
Hughes MD, Van Essel-Zandvliet EEM, Kerstjens HAM. Issues in the design of long-term clinical trials in asthma. Drug Inf J 1993;27:793-803. [Ref.ID 19992]
Kerstjens HAM, Brand PLP, Hughes MD, Robinson N J, Postma D S, Sluitter HJ, Bleecker ER, Dekhuijen PN, De Jong PM, Mengelers HJJ, Overbeek SE, Schoonbrood DFME, and the Dutch Chronic Non Specific Lung Disease Study Group. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413-9. [Ref.ID 18318]
Seleccionar todas
 1 a 13 de 13